CRP and COVID-19: We compared levels of laboratory biomarkers (CRP [C‐reactive protein], lactate dehydrogenase [LDH], d‐Dimer, total white blood cells [WBC], neutrophils, platelets, neutrophils to lymphocytes ratio [NLR], platelets to lymphocytes ratio [PLR], lymphocytes and monocytes) associated with high risks for severe COVID‐19 [13, 14, 15], between COVID‐19 patients with anti‐IFN‐I NAB (n = 13), and those negative for both BAB and NAB to IFN‐I (n = 299).